MDT shares were trading at $51.96 apiece as of about 11:30 a.m. today, up 1.5%.
St. Jude Medical (NYSE:STJ) pulled its Riata implantable cardiac defibrillator leads in 2010 after mounting evidence suggested that the Riata leads were prone to abrading through their insulation. The move cast a pall over over St. Jude’s newer ICD lead offerings, the Riata ST Optim and Durata leads.
Medical device company Uroplasty (NSDQ:UPI) will publish the results of a 3-year study on percutaneous tibial nerve stimulation in treatment of overactive bladder. The findings are slated to appear in the June edition of the The Journal of Urology.
Study patients received an average of 1.1 treatments per month and experienced improved outcomes, including reduced voiding frequency and acute urges to urinate, according to a press release.